Subscribe to our newsletter
Anna Cranston

Anna Cranston

Anna graduated in June 2015 with a first class BSc in Pharmacology from the University of Aberdeen.

She joined life sciences/pharmaceutical company TauRx Therapeutics Ltd. in October 2015 as a PhD student, working within translational neuroscience at the University of Aberdeen. Her project primarily focuses on the synaptic alterations and neuroinflammation observed within models of Alzheimer's Disease and Tauopathy.

Follow Anna:

From This Author

Here’s What We Think Alzheimer’s Does to the Brain

Around 50 million people worldwide are thought to have Alzheimer’s disease. And with rapidly aging populations in many countries, the number of sufferers is steadily rising. We know that Alzheimer’s is caused by problems in...

Singularity University, Singularity Hub, Singularity Summit, SU Labs, Singularity Labs, Exponential Medicine, Exponential Finance and all associated logos and design elements are trademarks and/or service marks of Singularity Education Group.

© 2021 Singularity Education Group. All Rights Reserved.

Singularity University is not a degree granting institution.